Concepedia

Howard Schwartz

HS

Statistics

Publications

33

Citations

3.7K

H-Index

24

Active since

1996

Affiliations

Moderna Therapeutics (United States)(Current)

Cancer Treatment Centers of America

University of Alabama at Birmingham

Brigham and Women's Hospital

Meridian Clinical Research

Howard Schwartz is an author at Moderna Therapeutics (United States) specializing in pharmacotherapy, pharmacology, and infectious diseases.

Publications per year

1996–2025

33

Publications

33

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

, , +13

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

Loren Laine, S. E. Harper, Thomas Simon et al. · Gastroenterology · 1999 · 476 citations · Full text

, , +13

Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia

Thomas Röth, Roberta Rogowski, Steven Hull et al. · SLEEP · 2007 · 338 citations · Full text

, , +17

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

Gregory T. Everson, Karen Sims, M. Rodríguez‐Torres et al. · Gastroenterology · 2013 · 199 citations · Full text

, , +17

Seven‐day therapy for <i>Helicobacter pylori</i> in the United States

Nimish Vakil, François Lanza, Howard Schwartz et al. · Alimentary Pharmacology & Therapeutics · 2004 · 171 citations · Full text

, , +16

1–5 of 33